David M. Brown
Impact in
- Ophthalmology top 0.01%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome
-
- Retinal Imaging and Analysis
Papers in
- Ophthalmology 102
- Retinal Diseases and Treatments 97
- Retinal and Optic Conditions 23
-
- Nanoparticles: synthesis and applications 33
- Co-authors
- David S. Boyer (27 shared papers)Vicki Stone (48 shared papers)Roman G. Rubio (5 shared papers)Peter A. Campochiaro (12 shared papers)Jeffrey S. Heier (25 shared papers)Charles C. Wykoff (60 shared papers)Amy Chen Rundle (3 shared papers)Namrata Saroj (6 shared papers)
- Journals
- Ophthalmology (28 papers)Investigative Ophthalmology & Visual Science (17 papers)Diabetes (14 papers)Retina (14 papers)Ophthalmology Retina (12 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
David M. Brown
292 papers receiving 15.0k citations
David M. Brown's Hit Papers
Peers
Comparison fields: 5 of 183
- Ophthalmology 8.3k
- Radiology, Nuclear Medicine and Imaging 3.0k
- Nephrology 506
- Health, Toxicology and Mutagenesis 822
- Clinical Biochemistry 312
Countries citing papers authored by David M. Brown
This map shows the geographic impact of David M. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Brown more than expected).
Fields of papers citing papers by David M. Brown
This network shows the impact of papers produced by David M. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Brown. The network helps show where David M. Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside David M. Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 299 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ranibizumab for Diabetic Macular Edema Hit paper breakdown → | 2012 | 1242 |
| 2 | Ranibizumab for Macular Edema following Central Retinal Vein Occlusion Hit paper breakdown → | 2010 | 933 |
| 3 | HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration Hit paper breakdown → | 2019 | 642 |
| 4 | Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study Hit paper breakdown → | 2011 | 584 |
| 5 | Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema Hit paper breakdown → | 2012 | 377 |
| 6 | 1980 | 354 | |
| 7 | Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion Hit paper breakdown → | 2014 | 314 |
| 8 | One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema Hit paper breakdown → | 2012 | 306 |
| 9 | 2008 | 285 | |
| 10 | 2012 | 280 | |
| 11 | 2013 | 269 | |
| 12 | 2009 | 260 | |
| 13 | 2015 | 224 | |
| 14 | Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders Hit paper breakdown → | 2021 | 223 |
| 15 | 2014 | 217 | |
| 16 | 1985 | 203 | |
| 17 | 2012 | 201 | |
| 18 | 2015 | 193 | |
| 19 | 2000 | 190 | |
| 20 | 1981 | 187 |
About David M. Brown
David M. Brown is a scholar working on Ophthalmology, Materials Chemistry, Molecular Biology, Health, Toxicology and Mutagenesis and Radiology, Nuclear Medicine and Imaging, having authored 299 papers that have together received 15.7k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (97 papers), Nanoparticles: synthesis and applications (33 papers), Air Quality and Health Impacts (25 papers), Retinal and Optic Conditions (23 papers), Retinal Imaging and Analysis (18 papers), Occupational and environmental lung diseases (16 papers), Proteoglycans and glycosaminoglycans research (10 papers) and Renal Diseases and Glomerulopathies (9 papers). The work is most often cited by research in Ophthalmology (8.3k citations), Radiology, Nuclear Medicine and Imaging (3.0k citations), Nephrology (506 citations), Health, Toxicology and Mutagenesis (822 citations) and Clinical Biochemistry (312 citations). David M. Brown has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David S. Boyer, Vicki Stone, Roman G. Rubio, Peter A. Campochiaro, Jeffrey S. Heier, Charles C. Wykoff, Amy Chen Rundle, Namrata Saroj, Wendy Yee Murahashi and Quan Dong Nguyen. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science, Diabetes, Retina and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.